Table 1 AML patients’ characteristics

From: MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia

Characteristics

Median (range)

No. (%)

Sex

 Male

 

25 (52.0)

 Female

 

23 (47.9)

WBC count, × 109/l

46.3.5 (1.2–671.22)

 

 Less than 10

 

20 (41.6)

 10–50

 

12 (25.0)

 50 or higher

 

7 (14.5)

 Not in detail

 

9 (18.7)

FAB

  

 M1

 

9 (15.5)

 M2

 

7 (12.1)

 M3

 

18 (31.0)

 M4

 

4 (6.8)

 M5

 

10 (17.2)

Cytogenetics

  

 ABL1/ETO

 

22 (45.8)

 PML/RARA

 

16 (33.3)

 Both negative

 

10 (20.8)

  1. Abbreviations: AML, acute myelogenous leukemia; CR: complete remission with 3 years clinical follow-up; FAB: French-American-British classification; PML/RARA: promyelocytic leukemia/retinoic acid receptor alpha; WBC, white blood cell.
Back to article page